The retailer's stock hit a 52-week high on Thursday of $39.15."The 'winners are really winning' theme continues to permeate retail, and Macy's has been one of the clearest examples," Credit Suisse analysts wrote in a report Thursday. "Beginning in '10, M started gaining share in the department store space, and in the past six months, the gains have only accelerated." Forward Annual Dividend Yield: 2.1% Rated "A+ (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin remained about the same as last year. Macy's has weak liquidity. Its Quick Ratio is 0.51, which demonstrates a lack of ability to meet its short-term cash needs. In the fourth quarter, stockholders' net worth increased 7.28% from the prior year. TheStreet Ratings' price target is $50.57. The stock closed Friday at $39.67 and has risen 23.28% year to date.
Merck The pharmaceutical company last week reiterated its 2012 fiscal-year earnings guidance of between $3.75 and $3.85 a share. "We see news flow for Merck accelerating in late 2012/early 2013 with several phase III readouts including odanacatib (osteoporosis), suvorexant (insomnia), Tredaptive (HPS2-THRIVE outcomes study), and extension data from the first phase III trial for anacetrapib (HDL)," JPMorgan analysts wrote in a report Thursday. "From an R&D budget standpoint, while Merck has a number of large outcomes studies currently running, the company is implementing a more disciplined approach to R&D that we believe could result in a more focused pipeline and lower expense levels over time." Forward Annual Dividend Yield: 4.5% Rated "A- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was about the same as it was last year. Merck has average liquidity. Its Quick Ratio is 1.43, which shows the company can technically meet its short-term cash needs. In the fourth quarter, stockholders' net worth was about the same as the previous year. TheStreet Ratings' price target is $43.65. The stock closed Friday at $37.60 and has ticked down 10 cents year to date.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV